1. American Cancer Society. Cancer Facts & Figures 2006. http://www.cancer.org/docroot/MED/content/MED_1_1_Most-Requested_Graphs_and_Figures_2006.asp (accessed September 12, 2006), part of www.cancer.org (accessed September 12, 2006).
2. U.S. National Institute of Health. Cancer Statistics http://www.cancer.gov/statistics/ (accessed September 15, 2006).
3. S. H. Jang, M. G. Wientjes, D. Lu, and J. L.-S. Au. Drug delivery and transport to solid tumors. Pharm. Res. 20:1337–1350 (2003).
4. Y. Matsumura and H. Maeda. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res. 46:6387–6392 (1986).
5. H. Maeda, J Wu, T. Sawa, Y. Matsumura, and K. Hori. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Rel. 65:271–284 (2000).